| Scalable gene synthesis by selective amplification of DNA pools from high-fidelity microchips S Kosuri, N Eroshenko, EM LeProust, M Super, J Way, JB Li, GM Church Nature biotechnology 28 (12), 1295-1299, 2010 | 397 | 2010 |
| Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures N Eroshenko, T Gill, MK Keaveney, GM Church, JM Trevejo, H Rajaniemi Nature biotechnology 38 (7), 789-791, 2020 | 163 | 2020 |
| Effect of substrate stiffness on early human embryonic stem cell differentiation N Eroshenko, R Ramachandran, VK Yadavalli, RR Rao Journal of biological engineering 7, 1-8, 2013 | 141 | 2013 |
| Mutants of Cre recombinase with improved accuracy N Eroshenko, GM Church Nature communications 4 (1), 2509, 2013 | 48 | 2013 |
| Role of bioinspired polymers in determination of pluripotent stem cell fate S Abraham, N Eroshenko, RR Rao Regenerative medicine 4 (4), 561-578, 2009 | 38 | 2009 |
| Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors S Iyer, E Xiao, K Alsayegh, N Eroshenko, MJ Riggs, JP Bennett, RR Rao Gene therapy 19 (5), 469-475, 2012 | 31 | 2012 |
| Gene Assembly from Chip‐Synthesized Oligonucleotides N Eroshenko, S Kosuri, AH Marblestone, N Conway, GM Church Current protocols in chemical biology 4 (1), 1-17, 2012 | 29 | 2012 |
| Orthogonal amplification and assembly of nucleic acid sequences GM Church, S Kosuri, N Eroshenko | 6 | 2012 |
| Modified ribonucleic acids and uses thereof N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn US Patent App. 18/451,386, 2023 | 2 | 2023 |
| Modified ribonucleic acids and uses thereof N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn US Patent 11,639,501, 2023 | 2 | 2023 |
| Mutant MYC fusion polypeptides and uses thereof T Gill, H Rajaniemi, N Eroshenko US Patent 11,987,605, 2024 | 1 | 2024 |
| Compositions including SBI adjuvants and methods of use thereof K Backman, N Dhar, N Eroshenko, T Gill, K Jammeh, M Keaveney, ... US Patent 11,771,758, 2023 | 1 | 2023 |
| Compositions comprising alpha-factor prepro sequence and uses thereof T Gill, K Jammeh, N Eroshenko US Patent App. 18/093,805, 2023 | 1 | 2023 |
| Linear covalently closed vectors and related compositions and methods thereof N Eroshenko, N Dhar US Patent App. 17/897,498, 2023 | 1 | 2023 |
| Linear covalently closed vectors and related compositions and methods thereof N Eroshenko, N Dhar US Patent 11,473,090, 2022 | 1 | 2022 |
| METHODS AND COMPOSITIONS FOR NUCLEIC ACID EXPRESSION INVOLVING INHIBITION of NF-kB PATHWAYS AND/OR IRF PATHWAYS N Eroshenko, H Rajaniemi, N Dhar US Patent App. 17/163,168, 2021 | 1 | 2021 |
| Methods and compositions for rna expression of myc inhibitors N Eroshenko, N Dhar, T Gill, M Keaveney, H Rajaniemi US Patent App. 17/269,787, 2021 | 1 | 2021 |
| Compositions and methods for RNA synthesis N Dhar, N Eroshenko, H Rajaniemi US Patent 12,139,734, 2024 | | 2024 |
| Modified ribonucleic acids and uses thereof N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn US Patent 12,098,369, 2024 | | 2024 |
| Modified ribonucleic acids and uses thereof N Dhar, M Keaveney, K Backman, E Webster, N Eroshenko, J Quinn US Patent 12,091,663, 2024 | | 2024 |
George ChurchHarvard Medical SchoolVerified email at harvard.edu